Delivery Order SPE2DB22D1106-SPE2DB24FFHD8

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,386.12 firm fixed price contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with an ultimate completion date of August 30, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a total ceiling value of $1,423.71 and an ultimate completion date of September 24, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 29, 2024. The $6,708.40 firm fixed-price contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of October 30, 2024 and is not associated with any set-aside requirements. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,042.29, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a completion date of April 18, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is the prime contractor. This contract is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a ceiling value of $12,288.44 and is a firm fixed-price delivery order contract with an ultimate completion date of August 6, 2024. The contract is not set aside for any particular business type. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous contracts by the DLA and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,104.90, is for the supply of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine. The contract has an ultimate completion date of February 4, 2025 and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, and has a ceiling value of $4,747.99. The contract is a Firm Fixed Price, Delivery Order, and does not have a set-aside designation. Amerisourcebergen is a large, for-profit organization that has been awarded numerous federal contracts and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a ceiling value of $3,985.44 and a completion date of October 18, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation in the amount of $23,963.42. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, which are hepatitis B vaccines. The award has a firm fixed-price and the ultimate completion date is July 19, 2024. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor that provides a wide range of medical supplies and prescription drugs to federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with a ceiling value of $2,057.56 and a completion date of January 13, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is the prime contractor, and...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFHD8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $27,977.54, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support medical supply requirements. The contract has a final completion date of August 19, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of essential pharmaceutical and medical products, including specialty medications, vaccines, and medical supplies, to support military treatment facilities, veterans' healthcare programs, and other federal healthcare providers.

Generated 11/15/24, 9:14 AM